Candidemia associated with COVID-19: risk factors and predisposition in critical patients
DOI:
https://doi.org/10.22491/2357-9730.132544Keywords:
COVID-19, candidemia, fungal co-infection, SARS-COV-2, risk factorsAbstract
Introduction: Coronavirus diasease 19 (COVID-19) is an infection caused by the new coronavirus - SARS-CoV-2 in 2019. The infection quickly spread throughout the world, establishing itself like a pandemic. Reports on secondary fungal co-infections in critically ill patients COVID-19 are still scarce and their dynamics are poorly understood. Candidemia is defined as the presence of Candida species in one or more blood cultures, being one of the most reported opportunistic fungal infections in intensive care units (ICU).
Methods: Three databases were used for the literary search: Pubmed, Science Direct, and Scopus, including articles published between 2020 and 2021.
Results: The incidence of candidemia in COVID-19 patients ranged up to 12% of COVID-19 reported cases. Candida albicans was the most prevalent species, followed by non-albicans species. The use of broad-spectrum antimicrobials, corticosteroids, central venous catheters, mechanical ventilation, parenteral nutrition, immunosuppressants such as tocilizumab and prolonged hospital stay were predisposing factors for the candidemia in COVID-19 patients.
Conclusion: There are strongly established risk factors that influence the establishment of candidemia in critically ill COVID-19 patients, which contributes to increased mortality in these patients. Finally, active surveillance by the medical team should be maintained for previous signs of fungal co-infection associated with SARS-CoV-2 contamination.
Downloads
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Natália Monteiro da Silva Rodrigues Coutinho, Gabriella da Rosa Monte Machado, Thaís Ferreira do Amaral, Mário Lettieri Teixeira, Alexandre Meneghello Fuentefria
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
